Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Researchers found a new area on chromosome 2 linked to a genetic hair loss condition.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

PRP is an effective and safe treatment for hair loss in women.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Early hair loss may indicate prostate issues.

Flutamide effectively reduces hair growth in women with hirsutism and improves acne and seborrhea without side effects.